This topic contains a solution. Click here to go to the answer

Author Question: Injections of insulin A) usually increase blood glucose. B) usually trigger eating. C) ... (Read 43 times)

ssal

  • Hero Member
  • *****
  • Posts: 572
Injections of insulin
 
  A) usually increase blood glucose.
  B) usually trigger eating.
  C) trigger eating only if the doses are large enough to produce reductions in blood glucose that are greater than those that would normally occur under typical free-feeding conditions.
  D) both A and B
  E) both A and C

Question 2

point theories of hunger and eating are inconsistent with
 
  A) eating-related evolutionary pressures as we understand them.
  B) the major effects on eating of taste, learning, and social factors.
  C) the failure of researchers to confirm that energy deficits are the usual stimuli for eating.
  D) all of the above
  E) both A and B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

chreslie

  • Sr. Member
  • ****
  • Posts: 307
Answer to Question 1

Answer: C

Answer to Question 2

Answer: D





 

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library